Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 96

1.

ErbB2 dephosphorylation and anti-proliferative effects of neuregulin-1 in ErbB2-overexpressing cells; re-evaluation of their low-affinity interaction.

Wang R, Iwakura Y, Araki K, Keino-Masu K, Masu M, Wang XY, Takei N, Higashiyama S, Nawa H.

Sci Rep. 2013;3:1402. doi: 10.1038/srep01402.

2.

Neuregulin-1 only induces trans-phosphorylation between ErbB receptor heterodimer partners.

Li Z, Mei Y, Liu X, Zhou M.

Cell Signal. 2007 Mar;19(3):466-71. Epub 2006 Sep 15.

PMID:
16978839
3.

[Neuregulin-1 promotes proliferation and migration of human coronary artery smooth muscle cells by enhancing its receptor phosphorylation].

He F, Gui C, Li L, Chen L, Qi B.

Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi. 2015 Dec;31(12):1643-6. Chinese.

PMID:
26648299
4.

Expression of heregulin alpha, erbB2, and erbB3 and their influences on proliferation of gastric epithelial cells.

Noguchi H, Sakamoto C, Wada K, Akamatsu T, Uchida T, Tatsuguchi A, Matsui H, Fukui H, Fujimori T, Kasuga M.

Gastroenterology. 1999 Nov;117(5):1119-27.

PMID:
10535875
5.
6.

The neuregulin-I/ErbB signaling system in development and disease.

Britsch S.

Adv Anat Embryol Cell Biol. 2007;190:1-65. Review.

PMID:
17432114
7.
8.

Epidermal growth factor receptor coexpression modulates susceptibility to Herceptin in HER2/neu overexpressing breast cancer cells via specific erbB-receptor interaction and activation.

Diermeier S, Horváth G, Knuechel-Clarke R, Hofstaedter F, Szöllosi J, Brockhoff G.

Exp Cell Res. 2005 Apr 1;304(2):604-19. Epub 2005 Jan 21.

PMID:
15748904
9.

c-Src modulates ErbB2 and ErbB3 heterocomplex formation and function.

Ishizawar RC, Miyake T, Parsons SJ.

Oncogene. 2007 May 24;26(24):3503-10. Epub 2006 Dec 18.

PMID:
17173075
10.

Interaction of integrin alpha(6)beta(4) with ErbB3 and implication in heregulin-induced ErbB3/ErbB2-mediated DNA synthesis.

Kawano S, Mizutani K, Miyata M, Ikeda W, Takai Y.

Genes Cells. 2010 Sep 1;15(9):995-1001. doi: 10.1111/j.1365-2443.2010.01438.x. Epub 2010 Jul 29.

11.

Neuregulin facilitates nerve regeneration by speeding Schwann cell migration via ErbB2/3-dependent FAK pathway.

Chang HM, Shyu MK, Tseng GF, Liu CH, Chang HS, Lan CT, Hsu WM, Liao WC.

PLoS One. 2013;8(1):e53444. doi: 10.1371/journal.pone.0053444. Epub 2013 Jan 2.

12.

ErbB receptors mediate both migratory and proliferative activities in human melanocytes and melanoma cells.

Gordon-Thomson C, Jones J, Mason RS, Moore GP.

Melanoma Res. 2005 Feb;15(1):21-8.

PMID:
15714117
13.
14.

ERBB3 (HER3) is a key sensor in the regulation of ERBB-mediated signaling in both low and high ERBB2 (HER2) expressing cancer cells.

Choi BK, Fan X, Deng H, Zhang N, An Z.

Cancer Med. 2012 Aug;1(1):28-38. doi: 10.1002/cam4.10. Epub 2012 Jul 15.

15.

An ERBB3/ERBB2 oncogenic unit plays a key role in NRG1 signaling and melanoma cell growth and survival.

Zhang K, Wong P, Duan J, Jacobs B, Borden EC, Bedogni B.

Pigment Cell Melanoma Res. 2013 May;26(3):408-14. doi: 10.1111/pcmr.12089. Epub 2013 Apr 2. Erratum in: Pigment Cell Melanoma Res. 2013 Jul;26(4):601.

PMID:
23480537
16.

Loss of Nrdp1 enhances ErbB2/ErbB3-dependent breast tumor cell growth.

Yen L, Cao Z, Wu X, Ingalla ER, Baron C, Young LJ, Gregg JP, Cardiff RD, Borowsky AD, Sweeney C, Carraway KL 3rd.

Cancer Res. 2006 Dec 1;66(23):11279-86.

17.

Protein kinase A-mediated gating of neuregulin-dependent ErbB2-ErbB3 activation underlies the synergistic action of cAMP on Schwann cell proliferation.

Monje PV, Athauda G, Wood PM.

J Biol Chem. 2008 Dec 5;283(49):34087-100. doi: 10.1074/jbc.M802318200. Epub 2008 Sep 17.

18.

Neuregulin-1-mediated ErbB2-ErbB3 signalling protects human trophoblasts against apoptosis to preserve differentiation.

Fock V, Plessl K, Draxler P, Otti GR, Fiala C, Knöfler M, Pollheimer J.

J Cell Sci. 2015 Dec 1;128(23):4306-16. doi: 10.1242/jcs.176933. Epub 2015 Oct 21.

19.

Therapeutic targeting of erbB3 with MM-121/SAR256212 enhances antitumor activity of paclitaxel against erbB2-overexpressing breast cancer.

Wang S, Huang J, Lyu H, Cai B, Yang X, Li F, Tan J, Edgerton SM, Thor AD, Lee CK, Liu B.

Breast Cancer Res. 2013;15(5):R101.

20.

The ErbB2/ErbB3 heterodimer functions as an oncogenic unit: ErbB2 requires ErbB3 to drive breast tumor cell proliferation.

Holbro T, Beerli RR, Maurer F, Koziczak M, Barbas CF 3rd, Hynes NE.

Proc Natl Acad Sci U S A. 2003 Jul 22;100(15):8933-8. Epub 2003 Jul 9.

Supplemental Content

Support Center